20.703 articles found

Unveiling Exosome Potential: Transforming Treatments for Neurodegeneration.

Tiwari A, Singh B, Singh GK, Meena J, Agrawal AK, Kumar S, Modi G.

ACS Appl Bio Mater · 2025-06-23

DOI: 10.1021/acsabm.5c00096PMID: 40550228

Central composite design-empowered colorimetric detection of levodopa by nanozyme based on tartaric acid-iridium nanoparticles: Towards visual assay by a pink color palette.

Davoodi-Rad K, Shokrollahi A, Shahdost-Fard F.

Anal Chim Acta · 2025-06-23

DOI: 10.1016/j.aca.2025.344362PMID: 40701728

A Real-World Study on Unstable Parkinson's Disease: Levodopa Dosage Management and the Role of Nonmotor Symptoms.

Stocchi F, Kulisevsky J, Jost WH.

Mov Disord Clin Pract · 2025-06-23

DOI: 10.1002/mdc3.70188PMID: 40545913

Effect of the combination pallidotomy-subthalamotomy performed in opposite cerebral hemispheres for the treatment of motor signs in Parkinson's disease.

Braña Miranda RC, Quintanal Cordero NE, Pavón Fuentes N, Pedroso Ibáñez I, Macías González R, Teijeiro Amador J, Abreu Duque A, Garbey Fernández R.

Neurologia (Engl Ed) · 2025-06-21

DOI: 10.1016/j.nrleng.2025.06.001PMID: 40550310

Intersection of H<sub>2</sub>S and Nrf2 signaling: Therapeutic opportunities for neurodegenerative diseases.

Soni P, Paswan S, Paul BD, Thomas B.

Neurotherapeutics · 2025-06-21

DOI: 10.1016/j.neurot.2025.e00627PMID: 40544135

Impulse Control Disorders and Other Compulsive Behaviours in Parkinson’s Disease – What Is Current Evidence of Treatment?

Gross A.

BJPsych open · 2025-06-20

Evaluation of the potential therapeutic effect of africanized honeybee venom (Apis mellifera Linnaeus) on levodopa-induced dyskinesias in mice.

Dantas CG, Araújo AAS, DE Albuquerque Junior RLC, Cândido EAF, Gomes MZ, Costa LPD.

An Acad Bras Cienc · 2025-06-20

DOI: 10.1590/0001-3765202520240826PMID: 40561270

A community-led initiative to de-risk and advance Parkinson's disease therapeutic targets.

Vaiana A, Behr J, Birol R, Blauwendraat C, Casey B, Chowdhury K, Citron M, Crapser J, Dardov V, Ducotterd F, Dumanis S, Dunlop J, Durborow M, Fiske B, Golden J, Hannestad J, Hung W, Kemp J, Kleiman R, Knight A, Koemeter-Cox A, Leuchter B, Logsdon BA, Marreiros R, Miller JE, Mitchell A, Mukherjee P, Navarro G, Nelson MR, Nikolich K, Otis T, Polinski N, Rastegar-Pouyani S, Reith AD, Riley E, Rubin L, Ryten M, Sadick J, Schwabe T, Sherer T, Silvergleid S, Singleton A, St Clair L, Stoehr J, Stone DJ, Sullivan J, Tanenbaum N, Tinelli E, Trimble K, Wang Y, Weninger S, Wiggenhauser N, Wood S, Schoepp D, Buggia-Prevot V, Padmanabhan S, Skibinski G.

NPJ Parkinsons Dis · 2025-06-20

DOI: 10.1038/s41531-025-01039-3PMID: 40541945

Effect of Safinamide on Non-Motor Symptoms and Quality of Life in Parkinson's Disease Patients According to Sex, Age, Disease Duration and Levodopa Equivalent Daily Dose.

Solleiro Vidal Á, Yáñez Baña R, Labandeira Guerra C, Cimas Hernando MI, Cabo López I, Paz González JM, Alonso Losada MG, Santos García D.

Brain Sci · 2025-06-20

DOI: 10.3390/brainsci15070666PMID: 40722259

Adaptive immunity in the pathogenesis and treatments of Parkinson's disease.

Du X, Akter S, Oludipe DB, Sil S, Zhang C, Gendelman HE, Mosley RL.

NeuroImmune Pharm Ther · 2025-06-20

DOI: 10.1515/nipt-2025-0008PMID: 40740678

Levodopa Sensing with a Nanosensor Array via a Low-Cost Near Infrared Readout.

Stegemann J, Augustin MN, Ackermann J, Fizzi NEH, Neutsch K, Gregor M, Herbertz S, Kruss S.

Anal Chem · 2025-06-20

DOI: 10.1021/acs.analchem.5c02320PMID: 40539248

Driving Therapeutic Innovation in Neurodegenerative Disease With Hydrogen Deuterium eXchange Mass Spectrometry.

Pierangelini A, Kessler BM, O'Brien DP.

Mol Cell Proteomics · 2025-06-20

DOI: 10.1016/j.mcpro.2025.101017PMID: 40544994